CXR - Concordia International Corp. Stock Price, News & Analysis

C$0.62 0.01 (1.64 %)
(As of 11/24/2017 11:45 AM ET)
Previous CloseC$0.61
Today's RangeC$0.60 - C$0.62
52-Week RangeC$0.58 - C$4.63
Volume44,085 shs
Average Volume351,776 shs
Market CapitalizationC$30.56 million
P/E RatioN/A
Dividend YieldN/A
Beta-2.64

About Concordia International Corp. (TSE:CXR)

Concordia International Corp. logoConcordia International Corp, formerly Concordia Healthcare Corp, is a Canada-based pharmaceutical company. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products. Its activities are divided into four segments: Concordia North America, includes sales of pharmaceutical products, such as Donnatal for the treatment of irritable bowel syndrome, Zonegran for the treatment of partial seizures in adults with epilepsy and Nilandron for the treatment of metastatic prostate cancer; Concordia International, includes a portfolio of branded and generic products that are sold to wholesalers, hospitals and pharmacies in over 100 countries, and focuses on acquisition, licensing and development of off-patent prescription medicines; Orphan Drugs, includes Photofrin, which is for the treatment of certain forms of rare cancer, and Corporate cost centre, includes centralized costs incurred by the Company.


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorHealthcare
SymbolTSE:CXR
CUSIPN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Dividend

Annual DividendN/A
Dividend YieldN/A

Profitability

Trailing EPSC($45.28)
Net IncomeN/A
Net Margins-628.57%
Return on EquityN/A
Return on Assets-130.11%

Miscellaneous

EmployeesN/A
Outstanding Shares51,144,000

Frequently Asked Questions for Concordia International Corp. (TSE:CXR)

What is Concordia International Corp.'s stock symbol?

Concordia International Corp. trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CXR."

How were Concordia International Corp.'s earnings last quarter?

Concordia International Corp. (TSE:CXR) issued its quarterly earnings data on Thursday, August, 13th. The company reported $1.04 earnings per share for the quarter, missing the Zacks' consensus estimate of $1.06 by $0.02. The firm had revenue of $95.34 million for the quarter, compared to analyst estimates of $87.41 million. View Concordia International Corp.'s Earnings History.

When will Concordia International Corp. make its next earnings announcement?

Concordia International Corp. is scheduled to release their next quarterly earnings announcement on Wednesday, March, 21st 2018. View Earnings Estimates for Concordia International Corp..

Who are some of Concordia International Corp.'s key competitors?

Who are Concordia International Corp.'s key executives?

Concordia International Corp.'s management team includes the folowing people:

  • Wayne Kreppner, President, Chief Operating Officer (Age 41)
  • Allan Oberman, Chief Executive Officer, Director (Age 59)
  • David J. Price, Chief Financial Officer
  • Graeme Duncan, President - Company's International Segment
  • Arijit Mookerjee, Managing Director, Chief Financial Officer - Operations
  • Adeel Ahmad, Chief Financial Officer of AMCo
  • Francesco Tallarico, Chief Legal Officer and Secretary
  • Jordan M. Kupinsky J.D., Non-Executive Independent Chairman of the Board (Age 44)
  • Douglas N. Deeth, Independent Director (Age 69)
  • Rochelle Fuhrmann, Independent Director (Age 47)

How do I buy Concordia International Corp. stock?

Shares of Concordia International Corp. and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Concordia International Corp.'s stock price today?

One share of Concordia International Corp. stock can currently be purchased for approximately C$0.62.

How big of a company is Concordia International Corp.?

Concordia International Corp. has a market capitalization of C$30.56 million.

How can I contact Concordia International Corp.?

Concordia International Corp.'s mailing address is 277 Lakeshore Rd E Suite 302, OAKVILLE, ON L6J 1H9, Canada. The company can be reached via phone at +1-905-8425150.


MarketBeat Community Rating for Concordia International Corp. (CXR)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  195 (Vote Outperform)
Underperform Votes:  165 (Vote Underperform)
Total Votes:  360
MarketBeat's community ratings are surveys of what our community members think about Concordia International Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Concordia International Corp. (TSE:CXR)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Sell (Score: 1.00)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for Concordia International Corp. (TSE:CXR)

Price Target History for Concordia International Corp. (TSE:CXR)

Analysts' Ratings History for Concordia International Corp. (TSE:CXR)

Show:
DateFirmActionRatingPrice TargetDetails
3/16/2017ScotiabankReiterated RatingUnderperformView Rating Details
2/9/2017TD SecuritiesDowngradeHold -> ReduceView Rating Details
12/8/2016Royal Bank Of CanadaDowngradeSector Perform -> UnderperformView Rating Details
11/7/2016Bloom BurtonDowngradeHold -> SellView Rating Details
8/15/2016Goldman Sachs Group, Inc. (The)Lower Price TargetC$34.00 -> C$17.00View Rating Details
8/15/2016CIBCDowngradeSector Perform -> UnderperformView Rating Details
3/21/2016Dundee SecuritiesLower Price TargetC$62.00 -> C$60.00View Rating Details
12/3/2015MackieDowngradeHoldView Rating Details
(Data available from 11/24/2015 forward)

Earnings

Earnings History and Estimates Chart for Concordia International Corp. (TSE:CXR)

Earnings by Quarter for Concordia International Corp. (TSE:CXR)

Earnings History by Quarter for Concordia International Corp. (TSE CXR)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/21/2018        
8/13/2015Q2C$1.06C$1.04C$87.41 millionC$95.34 millionViewListenView Earnings Details
8/13/2014C$0.19C($0.03)C$24.42 millionC$28.49 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Concordia International Corp. (TSE:CXR)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History by Quarter for Concordia International Corp. (TSE CXR)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/13/2016Quarterly$0.081.14%7/13/20167/29/20167/29/2016
4/13/2016Quarterly$0.080.95%4/13/20164/29/20164/29/2016
1/13/2016Quarterly$0.080.53%1/13/20161/29/20161/29/2016
10/13/2015Quarterly$0.080.62%10/13/201510/30/201510/30/2015
7/13/2015Quarterly$0.080.32%7/13/20157/31/20157/31/2015
4/13/2015Quarterly$0.080.35%4/13/20154/30/20154/30/2015
1/13/2015Quarterly$0.080.61%1/13/20151/31/20151/31/2015
10/10/2014Quarterly$0.080.76%10/10/201410/31/201410/31/2014
7/11/2014Quarterly$0.080.92%7/11/20147/31/20147/31/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Concordia International Corp. (TSE CXR)

Insider Trades by Quarter for Concordia International Corp. (TSE:CXR)

Insider Trades by Quarter for Concordia International Corp. (TSE CXR)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/25/2017Erin Colleen O'neilDirectorSell191C$1.74C$332.34
5/16/2017Graeme Neville DuncanDirectorSell7,065C$1.91C$13,494.15
2/1/2016Mark Laurence ThompsonDirectorBuy60C$28.77C$1,726.20
11/17/2015Rochelle FuhrmannDirectorBuy2,000C$31.67C$63,340.00
11/17/2015Wayne Walter KreppnerInsiderBuy3,000C$43.67C$131,010.00
11/16/2015Mark Laurence ThompsonDirectorBuy23,150C$43.36C$1,003,702.98
10/27/2015Edward BorkowskiDirectorBuy4,000C$30.43C$121,720.00
7/23/2015Jordan KupinskyDirectorSell43,000C$103.70C$4,459,272.00
7/17/2015Wayne Walter KreppnerInsiderSell4,800C$103.00C$494,400.00
7/3/2015Jordan KupinskyDirectorSell10,800C$92.21C$995,884.20
7/2/2015Jordan KupinskyDirectorSell45,900C$92.05C$4,224,934.35
6/26/2015Robert Steven AltmanInsiderSell62,500C$93.93C$5,870,893.75
6/22/2015John-Michel HussDirectorSell5,000C$92.00C$460,000.00
6/19/2015John-Michel HussDirectorSell4,300C$90.00C$387,000.00
6/11/2015John-Michel HussDirectorSell4,500C$90.02C$405,076.50
5/27/2015Saldanha Adrian DeInsiderBuy1,000C$80.61C$80,610.00
5/19/2015Adeel AhmadInsiderSell25,000C$83.80C$2,094,890.00
10/31/2014James Christopher ReebalsDirectorSell7,500C$37.25C$279,360.75
10/30/2014James Christopher ReebalsDirectorSell7,500C$37.06C$277,926.75
10/29/2014James Christopher ReebalsDirectorSell5,000C$37.07C$185,336.50
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Concordia International Corp. (TSE CXR)

Source:
DateHeadline
Concordia International Corp. :CXR-CA: Earnings Analysis: Q3, 2017 By the Numbers : November 23, 2017Concordia International Corp. :CXR-CA: Earnings Analysis: Q3, 2017 By the Numbers : November 23, 2017
finance.yahoo.com - November 23 at 4:11 PM
Edited Transcript of CXR.TO earnings conference call or presentation 14-Nov-17 1:30pm GMTEdited Transcript of CXR.TO earnings conference call or presentation 14-Nov-17 1:30pm GMT
finance.yahoo.com - November 14 at 11:09 PM
Concordia International Corp (CXR) Scheduled to Post Quarterly Earnings on TuesdayConcordia International Corp (CXR) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - November 7 at 9:06 AM
Concordia International Corp. Announces Release Date for Third Quarter 2017 Results - PR Newswire (press release)Concordia International Corp. Announces Release Date for Third Quarter 2017 Results - PR Newswire (press release)
www.prnewswire.com - November 2 at 4:46 AM
TSX Creeps Closer To Record Highs -- Canadian CommentaryTSX Creeps Closer To Record Highs -- Canadian Commentary
www.rttnews.com - October 20 at 7:12 PM
IIROC Trade Resumption - CXRIIROC Trade Resumption - CXR
finance.yahoo.com - October 20 at 7:11 PM
Update: TSX Posts Modest 30-Point Gain in Broad-Based Advance Led by Financials & IndustrialsUpdate: TSX Posts Modest 30-Point Gain in Broad-Based Advance Led by Financials & Industrials
www.nasdaq.com - October 12 at 5:20 AM
Canadian Stocks Turn Positive After EIA Report - Canadian CommentaryCanadian Stocks Turn Positive After EIA Report - Canadian Commentary
www.nasdaq.com - October 4 at 11:20 AM
Canadian Stocks Are Recovering Following Yesterdays Loss - Canadian CommentaryCanadian Stocks Are Recovering Following Yesterday's Loss - Canadian Commentary
www.nasdaq.com - September 27 at 6:50 PM
ETFs with exposure to Concordia International Corp. : September 6, 2017ETFs with exposure to Concordia International Corp. : September 6, 2017
finance.yahoo.com - September 6 at 12:19 AM
Concordia International Corp. Announces Release Date for DELIVER Strategy - PR Newswire (press release)Concordia International Corp. Announces Release Date for DELIVER Strategy - PR Newswire (press release)
www.prnewswire.com - September 1 at 11:00 PM
Canadian Stocks Are Rising On Strong GDP Data - Canadian CommentaryCanadian Stocks Are Rising On Strong GDP Data - Canadian Commentary
www.nasdaq.com - August 31 at 5:37 PM
Concordia International Corp. :CXR-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 18, 2017Concordia International Corp. :CXR-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 18, 2017
finance.yahoo.com - August 18 at 5:40 PM
RedHill Biopharma Announces US Commercialization Agreement for FDA-Approved GI Product Esomeprazole ... - NasdaqRedHill Biopharma Announces US Commercialization Agreement for FDA-Approved GI Product Esomeprazole ... - Nasdaq
www.nasdaq.com - August 17 at 4:32 PM
SHAREHOLDER ALERT: Morganti Legal, PC Advises Shareholders of Concordia International Corp. of a Motion ... - Business Wire (press release)SHAREHOLDER ALERT: Morganti Legal, PC Advises Shareholders of Concordia International Corp. of a Motion ... - Business Wire (press release)
www.businesswire.com - August 15 at 6:24 PM
Edited Transcript of CXR.TO earnings conference call or presentation 11-Aug-17 12:30pm GMTEdited Transcript of CXR.TO earnings conference call or presentation 11-Aug-17 12:30pm GMT
finance.yahoo.com - August 11 at 11:12 PM
Concordia International Corp (TSE:CXR) Set to Announce Earnings on FridayConcordia International Corp (TSE:CXR) Set to Announce Earnings on Friday
www.americanbankingnews.com - August 4 at 7:12 AM
Concordia International Corp. :CXR-CA: Earnings Analysis: Q1, 2017 By the Numbers : August 3, 2017Concordia International Corp. :CXR-CA: Earnings Analysis: Q1, 2017 By the Numbers : August 3, 2017
finance.yahoo.com - August 3 at 7:15 PM
Short seller Cohodes hits Canada again with latest target -Exchange IncomeShort seller Cohodes hits Canada again with latest target -Exchange Income
www.nasdaq.com - July 5 at 6:28 PM
Concordia Shares Lead TSX Gainers on Corporate UpdateConcordia Shares Lead TSX Gainers on Corporate Update
www.baystreet.ca - June 22 at 10:32 AM
Concordia International Corp. Announces Results of First CMA Stop/Go Decision - PR Newswire (press release)Concordia International Corp. Announces Results of First CMA Stop/Go Decision - PR Newswire (press release)
www.prnewswire.com - May 31 at 9:39 PM
Concordia International Corp. Announces Two New Appointments to ... - PR Newswire (press release)Concordia International Corp. Announces Two New Appointments to ... - PR Newswire (press release)
www.prnewswire.com - May 4 at 8:02 AM
Canadian Stocks Are Extending Recent Losses - Canadian CommentaryCanadian Stocks Are Extending Recent Losses - Canadian Commentary
www.nasdaq.com - April 13 at 11:46 AM
Canadian Stocks Are Paring Early Gains - Canadian CommentaryCanadian Stocks Are Paring Early Gains - Canadian Commentary
www.nasdaq.com - March 17 at 9:58 PM
Stocks Rally On Oil Rebound, Sober Fed -- Canadian CommentaryStocks Rally On Oil Rebound, Sober Fed -- Canadian Commentary
www.nasdaq.com - March 15 at 5:04 PM
Q4 2016 Concordia International Corp Earnings Release - Before Market OpenQ4 2016 Concordia International Corp Earnings Release - Before Market Open
biz.yahoo.com - March 15 at 9:47 AM
RedHill Biopharmas Co-Promotion Partner Concordia Announces ... - NasdaqRedHill Biopharma's Co-Promotion Partner Concordia Announces ... - Nasdaq
www.nasdaq.com - March 7 at 4:34 PM
Profile: Concordia International Corp (CXR.TO)Profile: Concordia International Corp (CXR.TO)
www.reuters.com - February 7 at 10:47 PM
Canadian Stocks Are Extending Their Losses In Early Trade - Canadian Commentary - NasdaqCanadian Stocks Are Extending Their Losses In Early Trade - Canadian Commentary - Nasdaq
www.nasdaq.com - January 31 at 5:15 PM
TSX Slightly Higher, Blackberry Makes Bet On Self-driving CarsTSX Slightly Higher, Blackberry Makes Bet On Self-driving Cars
www.rttnews.com - December 20 at 5:23 PM

Social Media

Financials

Financials are not available for this stock.

Chart

Concordia International Corp. (TSE CXR) Chart for Friday, November, 24, 2017
Loading chart…

This page was last updated on 11/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.